Company Filing History:
33 out of 377 
1 out of 832,891 Years Active: 1982-1993
Title: The Innovative Contributions of Patrick C Kung in Biotechnology
Introduction: Patrick C Kung, based in Bridgewater, NJ, has established himself as a prominent inventor in the field of biotechnology. With an impressive portfolio of 34 patents, his work primarily focuses on the development of monoclonal antibodies, which are crucial for both diagnostic and therapeutic applications in medicine.
Latest Patents: Among his latest patents, Kung's innovations include a hybrid cell line specifically designed for producing monoclonal antibodies targeting human monocytes. This hybrid cell line is created by fusing splenocytes from immunized BALB/cJ mice with P3X63Ag8U1 myeloma cells. The significance of this development lies in its ability to produce antibodies that can identify antigens found on normal human monocytes and granulocytes, which can lead to advancements in medical diagnostics and therapies.
Career Highlights: Throughout his career, Patrick C Kung has worked at several notable companies, including Ortho Pharmaceutical Corporation. His extensive experience in research and the pharmaceutical industry has contributed to significant advancements in antibody production and biotechnology.
Collaborations: Kung has collaborated with various professionals, including his coworker Gideon Goldstein. These collaborations have fostered a wealth of knowledge and innovation, further enhancing his contributions to the field.
Conclusion: Patrick C Kung's dedication to innovation in biotechnology is evident through his numerous patents and contributions to monoclonal antibody research. His work not only exemplifies the importance of scientific advancement but also highlights the collaborative efforts that drive innovation in the industry. As the field of biotechnology continues to evolve, Kung's contributions will undoubtedly remain influential in shaping future discoveries.